Stay updated on Daratumumab Combo in MRD+ Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Combo in MRD+ Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Combo in MRD+ Myeloma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The study page now displays the completed AURIGA trial record, including its design, treatment arms, outcome measures, eligibility criteria, and participating locations. It also includes study publications, record dates, and protocol and analysis-plan documents.
    Difference
    83%
    Check dated 2026-11-07T15:06:10.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T15:34:35.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A notice announces an NIH-wide terminology transition, stating that agencies are using “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T17:33:24.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1; the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T17:14:23.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The site footer’s revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T18:14:17.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Revision: v3.7.0 is displayed on the page, indicating a site version update. Several study document entries in the Study Documents section were removed, reducing access to materials such as the protocol and related plans.
    Difference
    18%
    Check dated 2026-09-19T22:09:21.000Z thumbnail image

Stay in the know with updates to Daratumumab Combo in MRD+ Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo in MRD+ Myeloma Clinical Trial page.